Neo Ivy Capital Management Eli Lilly & CO Transaction History

Neo Ivy Capital Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $633,436 - $846,977	-1,806 Reduced 91.49%	168 $78,000
Q4 2022 Mar 24, 2023	BUY	$321.55 - $374.67 $634,739 - $739,598	1,974 New	1,974 $722,000
Q2 2022 Aug 16, 2022	BUY	$278.73 - $327.27 $73,863 - $86,726	265 New	265 $85,000
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $740,206 - $918,599	-3,292 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$221.6 - $272.71 $723,967 - $890,943	3,267 Added 13068.0%	3,292 $540,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $124,037 - $160,441	-687 Reduced 96.49%	25 $6,000
Q1 2021 Oct 07, 2021	BUY	$164.32 - $212.72 $116,995 - $151,456	712 New	712 $133,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $226,869 - $300,203	-1,739 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$146.22 - $169.13 $1.66 Million - $1.92 Million	-11,323 Reduced 86.69%	1,739 $257,000
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $1.33 Million - $1.6 Million	9,770 Added 296.78%	13,062 $2.14 Million
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $435,998 - $524,719	3,196 Added 3329.17%	3,292 $540,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $11,428 - $14,145	96 New	96 $13,000
Q3 2019 Nov 21, 2019	SELL	$106.79 - $116.16 $1.39 Million - $1.52 Million	-13,062 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$110.79 - $129.32 $1.45 Million - $1.69 Million	13,062 New	13,062 $1.45 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.